Oral liquid suspension of mycophenolate mofetil immunosuppressant, 100 mg per dose

This code represents mycophenolate mofetil, an immunosuppressant medication formulated as an oral suspension, specifically in a 100 mg dosage. It is primarily used to prevent organ rejection in transplant recipients and in the treatment of certain autoimmune diseases.

Use this code when billing for the oral suspension form of mycophenolate mofetil (Myhibbin brand or generic equivalent) administered to a patient. Documentation should clearly indicate the drug, dosage, route of administration (oral), and the medical necessity for its use, such as post-transplant immunosuppression or autoimmune disease management.

• Ensure the documentation specifies "oral suspension" to differentiate from other formulations (e.g., capsules, tablets).